A phase II randomized study of cisplatin (CDDP), raltitrexed (TOM), levofolinic acid (LFA), and 5-fluorouracil (5-FU), or CDDP, methotrexate (MTX), LFA and 5-FU in locally advanced (LAD) or metastatic (M) head and neck cancer (HNC)
Keyword(s):
Phase Ii
◽
2008 ◽
Vol 26
(15_suppl)
◽
pp. 6000-6000
◽
2014 ◽
Vol 32
(15_suppl)
◽
pp. e17044-e17044
◽